| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2975b972a07e92f547f8f735d8fda82e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 |
| filingDate |
2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac44d699184d5fd966f6a685b6e6ed5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28ecc478ca3d38aa386b2f4d828c25e9 |
| publicationDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002143030-A1 |
| titleOfInvention |
Treatment of gastroparesis in certain patient groups |
| abstract |
Methods for treating specific patient groups for gastroparesis are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions comprising quinolinones (and derivatives) in patients with symptoms of gastroparesis who are otherwise free of cardiac disease and/or who have not been given organic nitrates. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2194044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018112061-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2194044-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628150-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8367702-B2 |
| priorityDate |
2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |